Trials / Conditions / Neuromyelitis Optica Spectrum Disorder Attack

Neuromyelitis Optica Spectrum Disorder Attack

5 registered clinical trials studyying Neuromyelitis Optica Spectrum Disorder Attack — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study NCT07410039	Chinese PLA General Hospital	Phase 4
Recruiting	Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder NCT07184840	Tianjin Medical University General Hospital	Phase 2
Withdrawn	Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder NCT06673394	Tianjin Medical University General Hospital	Phase 2
Unknown	Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Ac NCT05605951	Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul	—
Terminated	Diagnosis of ON With or Without MS or NMOSD NCT04131764	Jagannadha R Avasarala	—